AU1392301A - Interferon gamma for the treatment of asthma - Google Patents

Interferon gamma for the treatment of asthma Download PDF

Info

Publication number
AU1392301A
AU1392301A AU13923/01A AU1392301A AU1392301A AU 1392301 A AU1392301 A AU 1392301A AU 13923/01 A AU13923/01 A AU 13923/01A AU 1392301 A AU1392301 A AU 1392301A AU 1392301 A AU1392301 A AU 1392301A
Authority
AU
Australia
Prior art keywords
ifn
glucocorticoid
asthma
dosage
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13923/01A
Other languages
English (en)
Inventor
Lutz-Henning Block
Rolf Ziesche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MONDOBIOTECH SA
Original Assignee
MONDOBIOTECH SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MONDOBIOTECH SA filed Critical MONDOBIOTECH SA
Publication of AU1392301A publication Critical patent/AU1392301A/en
Assigned to MONDOBIOTECH SA reassignment MONDOBIOTECH SA Alteration of Name(s) of Applicant(s) under S113 Assignors: BLOCK, LUTZ-HENNING
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU13923/01A 1999-11-10 2000-11-06 Interferon gamma for the treatment of asthma Abandoned AU1392301A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99122357 1999-11-10
EP99122357 1999-11-10
PCT/EP2000/010941 WO2001034180A2 (fr) 1999-11-10 2000-11-06 Interferon gamma pour le traitement de l'asthme

Publications (1)

Publication Number Publication Date
AU1392301A true AU1392301A (en) 2001-06-06

Family

ID=8239362

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13923/01A Abandoned AU1392301A (en) 1999-11-10 2000-11-06 Interferon gamma for the treatment of asthma

Country Status (5)

Country Link
EP (1) EP1227831A2 (fr)
JP (1) JP2003513933A (fr)
AU (1) AU1392301A (fr)
CA (1) CA2387089A1 (fr)
WO (1) WO2001034180A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR381601A0 (en) * 2001-03-19 2001-04-12 Monash University Method of treating respiratory conditions
US6911198B2 (en) 2001-09-17 2005-06-28 Yeda Research And Development Co. Ltd. Method and pharmaceutical composition for treating inflammation
WO2003051388A2 (fr) * 2001-12-18 2003-06-26 Mondobiotech Laboratories Anstalt Nouvelle composition pharmaceutique d'interferon gamma ou de pirfenidone associe a des agents moleculaires diagnostiques permettant un traitement ameliore des affections pulmonaires interstitielles
EP1430902A1 (fr) * 2002-12-20 2004-06-23 Mondobiotech Laboratories Anstalt Composition pharmaceutique comprenant l'interferon gamma avec diagnostic moléculaire pour un meilleur traitment de l'asthme
US20070031377A1 (en) * 2003-03-28 2007-02-08 Stany Depraetere Treatment of type 1 immune response-mediated inflammatory lung disease by modulation of ifn-gamma activity
EP1516627A1 (fr) * 2003-09-17 2005-03-23 CONARIS research institute AG Interferon-gamma pour le traitement de maladies associées au gène NOD2
US11135223B2 (en) 2016-01-22 2021-10-05 Yale University Compositions and methods for inhibiting Dkk-1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
EP0311616B1 (fr) * 1986-06-17 1991-09-25 Biogen, Inc. Combinaisons d'interferons gamma et d'agents anti-inflammatoires ou anti-pyretiques pour le traitement de maladies
DK0502997T3 (da) * 1989-12-01 1995-07-17 Childrens Medical Center Behandling af atopiske sygdomme med gamma-interferon
EP0795332B1 (fr) * 1996-03-14 2005-06-01 Mondobiotech Interferon SA Utilisation médicale de gamma interféron dans les maladies pulmonaires interstitielles

Also Published As

Publication number Publication date
EP1227831A2 (fr) 2002-08-07
CA2387089A1 (fr) 2001-05-17
JP2003513933A (ja) 2003-04-15
WO2001034180A3 (fr) 2001-11-08
WO2001034180A2 (fr) 2001-05-17

Similar Documents

Publication Publication Date Title
US7183381B2 (en) Composition of lactoferrin related peptides and uses thereof
IFNB Multiple Sclerosis Study Group Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis: I. Clinical results of a multicenter, randomized, double‐blind, placebo-controlled trial
JP2002511385A5 (fr)
WO2012096411A1 (fr) Méthode de prévention ou traitement de maladie intestinale inflammatoire réfractaire
EP1369119B1 (fr) Agents de regulation d'expression d'il-12
JPH06157343A (ja) ある種の疾病の予防および治療用医薬を製造するためのカリクレインインヒビターの使用
AU2010203446B2 (en) Prevention and/or treatment of multiple organ dysfunction syndrome with interleukin-22
AU1392301A (en) Interferon gamma for the treatment of asthma
WO2004084927A2 (fr) Procedes d'induction d'immunotolerance et compositions utilisees dans ces procedes
EP0795332B1 (fr) Utilisation médicale de gamma interféron dans les maladies pulmonaires interstitielles
JP2000501085A (ja) 多発性硬化症を治療するためのペントキシフィリンと▲ｉ▼型インターフェロン類の併用
JPH04275231A (ja) 事故結果として多外傷を有する危険な患者に於て、臓器拒絶の予防及び（又は）処置に、スーパーオキシドジスムターゼを使用する方法
JP4023863B2 (ja) Ｉｌ−６を含む血清尿酸値低下剤
RU2721282C2 (ru) Способ лечения рассеянного склероза (варианты)
US20230210942A1 (en) Methods and compositions for modulating endothelial cell dysfunction
JP2002220343A (ja) びまん性肺疾患延命剤
CN111249300B (zh) 褪黑素联合甲钴胺在治疗糖尿病创面愈合障碍中的应用
US11819508B2 (en) Miltefosine for the treatment of viral infections including covid-19
WO1993000921A1 (fr) Remede a l'osteoporose
JP2012025734A (ja) 骨髄異形性症候群を治療するための組成物および方法
US20220387475A1 (en) Methods and compositions for treating endometriosis
Vittorio et al. New biologic agents for the treatment of cutaneous T-cell lymphoma
RU2195314C1 (ru) Способ лечения больных с атопическим дерматитом
JPH10273448A (ja) アトピー性疾患治療のための口腔内投与用治療薬
CN116916908A (zh) 用于保持治疗化合物完整性的edta和egta

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: MONDOBIOTECH SA

Free format text: THE FORMER OWNER WAS: LUTZ-HENNING BLOCK